Back to today’s briefing

Story perspectives

Varenicline Helps 51% of Teens Quit Vaping

5/8/2025

28 6

Summary

Story summary

A groundbreaking clinical trial revealed that varenicline, a smoking cessation drug, enabled 51% of teens to successfully quit vaping, a stark contrast to just 14% on a placebo. Published in the Journal of the American Medical Association, this study underscores the drug's promise in alleviating nicotine cravings and withdrawal symptoms among adolescents.

1 of 1

Story summary

A groundbreaking clinical trial revealed that varenicline, a smoking cessation drug, enabled 51% of teens to successfully quit vaping, a stark contrast to just 14% on a placebo. Published in the Journal of the American Medical Association, this study underscores the drug's promise in alleviating nicotine cravings and withdrawal symptoms among adolescents.